3-Month Injection Contraception And Obesity In Puskesmas Banding Agung
Article Sidebar
Published:
Sep 19, 2023
Keywords:
Contraception, Injectable, 3-Month, Obesity, Weight Gain
Section
Articles
Statistics Article
Article View : 84 Times
Main Article Content
Abstract
The 3-month injectable contraception is a highly effective method of hormonal contraception that prevents pregnancy. However, some acceptors may experience side effects, such as weight gain. This research aims to determine the relationship between the duration of 3 months of injectable contraceptive use and the incidence of obesity at the Health Center of Banding Agung. The study used a correlational analytic method with a cross-sectional approach. The population consisted of all mothers who had used the 3-month injection contraception for three months, with a total of 1,250 acceptors. The sample size was 93 respondents, and measuring tools used were family planning visit books, medical records, scales, and height measuring devices (GEA brand). The study found that those who used the 3-month injection contraception for over two years had the same number of obese people, namely 74 respondents (79.6%). The Fisher's Exact test obtained a p-value of <0.001 (? = 0.05), indicating a long-term relationship between 3-month injection contraception and obesity at the Banding Agung Inpatient Health Center. Understanding this link and providing proper services and education can help women make informed contraceptive decisions for their well-being.
Article Details
How to Cite
Kholilah, K., Yuliati, L. ., & Wijayanti, I. T. (2023). 3-Month Injection Contraception And Obesity In Puskesmas Banding Agung. Journal of Midwifery and Nursing, 5(3), 98-104. https://doi.org/10.35335/jmn.v5i3.4045
References
[1] R. Kemenkes, Pedoman Pelayanan Kontrasepsi dan Keluarga Berencana. Jakarta: Direktorat Jendral Kesehatan Keluarga, 20221.
[2] L. Lopez et al., “Progestin-only contraceptives: effects on weight,” Cochrane Database Syst Rev, vol. 2016, no. 8, p. CD008815, 2016, doi: 10.1002/14651858.CD008815.pub4.
[3] J. Sims, E. Lutz, K. Wallace, W. Kassahun-Yimer, C. Ngwudike, and J. Shwayder, “Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women,” Eur J Contracept Reprod Heal. Care, vol. 25, no. 1, pp. 54–59, 2020, doi: 10.1080/13625187.2019.1709963. Epub 2020 Jan 13.
[4] V. Sari and W. Afridah, “Literature Review: Peningkatan Berat Badan Pada Akseptor KB Suntik Tiga Bulan,” in PROSIDING NATIONAL CONFERENCE FOR UMMAH, 2020. [Online]. Available: https://conferences.unusa.ac.id/index.php/NCU2020/article/view/640/313
[5] Z. Zubaidah, “Hubungan pemakaian KB suntik 3 bulan dengan berat badan di praktik mandiri,” J. Ilmu Kesehat. Insa. Sehat, vol. 9, no. 2, pp. 138–142, 2021, [Online]. Available: https://jurnalstikesintanmartapura.com/index.php/jikis/article/download/30/32
[6] H. Ibrahim, T. A. T. Ismail, and N. Hashim, “Comparison of body weight among hormonal and non-hormonal users in a Malaysian cohort,” J Taibah Univ Med Sci, vol. 14, no. 1, pp. 25–30, 2018, doi: 10.1016/j.jtumed.2018.11.012.
[7] L. Bahamondes, “Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception did not influence early discontinuation,” EClinicalMedicine, vol. Apr, no. 34, p. 100857, 2021, doi: 10.1016/j.eclinm.2021.100857.
[8] M. F. Zerihun, T. Malik, Y. M. Ferede, T. Bekele, and Y. Yeshaw, “Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia,” BMC Res. Notes, vol. 12, p. 512, 2019, doi: https://doi.org/10.1186/s13104-019-4555-y.
[9] B. Mags et al., “Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial,” EClinicalMedicine, vol. Apr, no. 34, p. 100800, 2021, doi: 10.1016/j.eclinm.2021.100800.
[10] Z. Vickery, T. Madden, Q. Zhao, G. Secura, J. Allsworth, and J. Peipert, “Weight change at 12 months in users of three progestin-only contraceptive methods,” Contraception, vol. 88, no. 4, pp. 503–8, 2013, doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.
[11] FSRH, “FSRH CEU Statement: Contraception and Weight Gain 12 August 2019,” Edinburg, 2019.
[12] R. Kemenkes, “Epidemi Obesitas,” Jakarta, 2018. [Online]. Available: https://p2ptm.kemkes.go.id/uploads/N2VaaXIxZGZwWFpEL1VlRFdQQ3ZRZz09/2018/02/FactSheet_Obesitas_Kit_Informasi_Obesitas.pdf
[13] WHO, “Obesity and overweight,” Genewa, 2018. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
[14] B. S. Selatan, “Sumatera Selatan dalam angka 2021,” Palembang, 2022. [Online]. Available: https://sumsel.bps.go.id/publication/2021/02/26/147e35ceefdd0719b3d563d4/provinsi-sumatera-selatan-dalam-angka-2021.html
[15] S. Suciana, R. Rajuddin, and A. Gani, “Hubungan Lama Penggunaan Kontrasepsi Depo Medroksiprogesteron Asetat (DMPA) Dengan Obesitas,” AVERROUS J. Kedokt. dan Kesehat. Malikussaleh, vol. 3, 2018, doi: 10.29103/averrous.v3i1.448.
[16] Y. Kartika and S. Ronoatmodjo, “Penggunaan Kontrasepsi Hormonal Dan Obesitas Pada Wanita Usia Subur Di Indonesia: Analisis Data Ifls 5 Tahun 2014,” Kesehat. Reproduksi, vol. 10, no. 2, pp. 101–10, 2020, [Online]. Available: http://ejournal2.bkpk.kemkes.go.id/index.php/kespro/article/view/2412
[17] D. Noviantari, N. G. K. Sriasih, and J. Mauliku, “Hubungan Antara Lama Penggunaan Kontrasepsi Suntik Depo Medroxyprogesterone Acetate Dengan Peningkatan Berat Badan Akseptor Di Praktik Mandiri Bidan Hs Denpasar Barat Tahun 2019,” J. Ilm. Kebidanan, vol. 7, no. 2, pp. 71–78, 2019, [Online]. Available: https://repo.itskesicme.ac.id/6294/1/BAB 1-6 (NENY).pdf
[18] W. Pramudita, N. Setiyawati, and W. N. Muslihatun, “Faktor-Faktor Yang Mempengaruhi Lama Penggunaan KB Suntik Pada Akseptor Umur Lebih Dari 35 Tahun Di Desa Srihardono Kecamatan Pundong Bantul Tahun 2019,” Poltekkes Kemenkes Yogyakarta, 2019. [Online]. Available: http://eprints.poltekkesjogja.ac.id/2271/
[19] T. B. Rahayu and N. WIjanarko, “Efek Samping Akseptor KB Suntik Depo Medroksi Progesterone Asetat (DMPA) Setelah 2 Tahun Pemakaian,” J. Kesehat. “Samodra Ilmu,” vol. 8, no. 1, pp. 32–38, 2017, [Online]. Available: https://media.neliti.com/media/publications/137838-ID-efek-samping-akseptor-kb-suntik-depo-med.pdf
[20] Y. Septianingrum, E. M. Wardani, and Y. Kartini, “Faktor-faktor yang mempengaruhi tingginya akseptor KB suntik 3 bulan,” J. Ners dan Kebidanan, vol. 5, no. 1, pp. 015–019, 2018, [Online]. Available: http://repository.unusa.ac.id/2748/1/Faktor-Faktor Yang Mempengaruhi Tingginya Akseptor Kb Suntik 3 Bulan.pdf
[21] P. Silva, S. Qadir, A. Fernandes, L. Bahamondes, and J. F. Peipert, “Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review,” Braz J Med Biol Res, vol. 51, no. 6, p. e7575, 2018, doi: 10.1590/1414-431x20187575. Epub 2018 Apr 23.
[22] M. Zerihun, T. Malik, Y. Ferede, T. Bekele, and Y. Yeshaw, “Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia,” BMC Res Notes, vol. 12, no. 1, p. 512, 2021, doi: 10.1186/s13104-019-4555-y.
[23] S. Suciana, R. Rajuddin, and A. Gani, “Hubungan Lama Penggunaan Kontrasepsi Depo Medroksiprogesteron Asetat (DMPA) Dengan Obesitas,” J. Averrous, vol. 3, no. 1, pp. 46–55, 2017, [Online]. Available: https://ojs.unimal.ac.id/index.php/averrous/article/view/448
[24] H. Hadina, K. Kartini, and P. N. Sakinah, “Waktu Penggunaan Depo Medroxy Progesterone Acetate Terhadap Peningkatan Indeks Massa Tubuh (IMT) Ibu,” Poltekita J. Ilmu Kesehat., vol. 13, no. 2, pp. 76–80, 2019.
[25] Shokoufeh Dianat et al., “Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review,” Obs. Gynecol, vol. 133, no. 2, pp. 332–341, 2019, doi: 10.1097/AOG.0000000000003089.
[2] L. Lopez et al., “Progestin-only contraceptives: effects on weight,” Cochrane Database Syst Rev, vol. 2016, no. 8, p. CD008815, 2016, doi: 10.1002/14651858.CD008815.pub4.
[3] J. Sims, E. Lutz, K. Wallace, W. Kassahun-Yimer, C. Ngwudike, and J. Shwayder, “Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women,” Eur J Contracept Reprod Heal. Care, vol. 25, no. 1, pp. 54–59, 2020, doi: 10.1080/13625187.2019.1709963. Epub 2020 Jan 13.
[4] V. Sari and W. Afridah, “Literature Review: Peningkatan Berat Badan Pada Akseptor KB Suntik Tiga Bulan,” in PROSIDING NATIONAL CONFERENCE FOR UMMAH, 2020. [Online]. Available: https://conferences.unusa.ac.id/index.php/NCU2020/article/view/640/313
[5] Z. Zubaidah, “Hubungan pemakaian KB suntik 3 bulan dengan berat badan di praktik mandiri,” J. Ilmu Kesehat. Insa. Sehat, vol. 9, no. 2, pp. 138–142, 2021, [Online]. Available: https://jurnalstikesintanmartapura.com/index.php/jikis/article/download/30/32
[6] H. Ibrahim, T. A. T. Ismail, and N. Hashim, “Comparison of body weight among hormonal and non-hormonal users in a Malaysian cohort,” J Taibah Univ Med Sci, vol. 14, no. 1, pp. 25–30, 2018, doi: 10.1016/j.jtumed.2018.11.012.
[7] L. Bahamondes, “Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception did not influence early discontinuation,” EClinicalMedicine, vol. Apr, no. 34, p. 100857, 2021, doi: 10.1016/j.eclinm.2021.100857.
[8] M. F. Zerihun, T. Malik, Y. M. Ferede, T. Bekele, and Y. Yeshaw, “Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia,” BMC Res. Notes, vol. 12, p. 512, 2019, doi: https://doi.org/10.1186/s13104-019-4555-y.
[9] B. Mags et al., “Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial,” EClinicalMedicine, vol. Apr, no. 34, p. 100800, 2021, doi: 10.1016/j.eclinm.2021.100800.
[10] Z. Vickery, T. Madden, Q. Zhao, G. Secura, J. Allsworth, and J. Peipert, “Weight change at 12 months in users of three progestin-only contraceptive methods,” Contraception, vol. 88, no. 4, pp. 503–8, 2013, doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.
[11] FSRH, “FSRH CEU Statement: Contraception and Weight Gain 12 August 2019,” Edinburg, 2019.
[12] R. Kemenkes, “Epidemi Obesitas,” Jakarta, 2018. [Online]. Available: https://p2ptm.kemkes.go.id/uploads/N2VaaXIxZGZwWFpEL1VlRFdQQ3ZRZz09/2018/02/FactSheet_Obesitas_Kit_Informasi_Obesitas.pdf
[13] WHO, “Obesity and overweight,” Genewa, 2018. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
[14] B. S. Selatan, “Sumatera Selatan dalam angka 2021,” Palembang, 2022. [Online]. Available: https://sumsel.bps.go.id/publication/2021/02/26/147e35ceefdd0719b3d563d4/provinsi-sumatera-selatan-dalam-angka-2021.html
[15] S. Suciana, R. Rajuddin, and A. Gani, “Hubungan Lama Penggunaan Kontrasepsi Depo Medroksiprogesteron Asetat (DMPA) Dengan Obesitas,” AVERROUS J. Kedokt. dan Kesehat. Malikussaleh, vol. 3, 2018, doi: 10.29103/averrous.v3i1.448.
[16] Y. Kartika and S. Ronoatmodjo, “Penggunaan Kontrasepsi Hormonal Dan Obesitas Pada Wanita Usia Subur Di Indonesia: Analisis Data Ifls 5 Tahun 2014,” Kesehat. Reproduksi, vol. 10, no. 2, pp. 101–10, 2020, [Online]. Available: http://ejournal2.bkpk.kemkes.go.id/index.php/kespro/article/view/2412
[17] D. Noviantari, N. G. K. Sriasih, and J. Mauliku, “Hubungan Antara Lama Penggunaan Kontrasepsi Suntik Depo Medroxyprogesterone Acetate Dengan Peningkatan Berat Badan Akseptor Di Praktik Mandiri Bidan Hs Denpasar Barat Tahun 2019,” J. Ilm. Kebidanan, vol. 7, no. 2, pp. 71–78, 2019, [Online]. Available: https://repo.itskesicme.ac.id/6294/1/BAB 1-6 (NENY).pdf
[18] W. Pramudita, N. Setiyawati, and W. N. Muslihatun, “Faktor-Faktor Yang Mempengaruhi Lama Penggunaan KB Suntik Pada Akseptor Umur Lebih Dari 35 Tahun Di Desa Srihardono Kecamatan Pundong Bantul Tahun 2019,” Poltekkes Kemenkes Yogyakarta, 2019. [Online]. Available: http://eprints.poltekkesjogja.ac.id/2271/
[19] T. B. Rahayu and N. WIjanarko, “Efek Samping Akseptor KB Suntik Depo Medroksi Progesterone Asetat (DMPA) Setelah 2 Tahun Pemakaian,” J. Kesehat. “Samodra Ilmu,” vol. 8, no. 1, pp. 32–38, 2017, [Online]. Available: https://media.neliti.com/media/publications/137838-ID-efek-samping-akseptor-kb-suntik-depo-med.pdf
[20] Y. Septianingrum, E. M. Wardani, and Y. Kartini, “Faktor-faktor yang mempengaruhi tingginya akseptor KB suntik 3 bulan,” J. Ners dan Kebidanan, vol. 5, no. 1, pp. 015–019, 2018, [Online]. Available: http://repository.unusa.ac.id/2748/1/Faktor-Faktor Yang Mempengaruhi Tingginya Akseptor Kb Suntik 3 Bulan.pdf
[21] P. Silva, S. Qadir, A. Fernandes, L. Bahamondes, and J. F. Peipert, “Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review,” Braz J Med Biol Res, vol. 51, no. 6, p. e7575, 2018, doi: 10.1590/1414-431x20187575. Epub 2018 Apr 23.
[22] M. Zerihun, T. Malik, Y. Ferede, T. Bekele, and Y. Yeshaw, “Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia,” BMC Res Notes, vol. 12, no. 1, p. 512, 2021, doi: 10.1186/s13104-019-4555-y.
[23] S. Suciana, R. Rajuddin, and A. Gani, “Hubungan Lama Penggunaan Kontrasepsi Depo Medroksiprogesteron Asetat (DMPA) Dengan Obesitas,” J. Averrous, vol. 3, no. 1, pp. 46–55, 2017, [Online]. Available: https://ojs.unimal.ac.id/index.php/averrous/article/view/448
[24] H. Hadina, K. Kartini, and P. N. Sakinah, “Waktu Penggunaan Depo Medroxy Progesterone Acetate Terhadap Peningkatan Indeks Massa Tubuh (IMT) Ibu,” Poltekita J. Ilmu Kesehat., vol. 13, no. 2, pp. 76–80, 2019.
[25] Shokoufeh Dianat et al., “Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review,” Obs. Gynecol, vol. 133, no. 2, pp. 332–341, 2019, doi: 10.1097/AOG.0000000000003089.